Drugs Made In America Acquisition II Corp. - (DMII) closed at $10.22 on November 5, 2026, unchanged from the previous close, on volume of 102,132 shares (30-day average 172,129).
Data as of November 5, 2026.
No headlines found.
No press releases found.
No news found.
Drugs Made In America Acquisition II Corp is a blank check Company.
Drugs Made In America Acquisition II Corp. - trades on the NASDAQ stock market under the symbol DMII.
As of November 6, 2026, DMII stock price declined to $10.21 with 70,114 million shares trading.
DMII has a beta of 0.02, meaning it tends to be less sensitive to market movements. DMII has a correlation of 0.02 to the broad based SPY ETF.
DMII has a market cap of $650.38 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that DMII belongs to (by Net Assets): SPCK.
DMII support price is $10.21 and resistance is $10.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DMII shares will trade within this expected range on the day.
